Results · Apr-Jun 2026
Link Pharma Chem Q1 FY27 results
Sales grew 12% to ₹8.8 crore from ₹7.8 crore in Apr-Jun 2025.
Operating profit fell 29% to ₹0.46 crore, an operating margin of 5.2% (down 3.0 points from a year ago).
Net profit fell 21% to ₹0.32 crore from ₹0.4 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +33%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 8.8 | 7.8 | +12% |
| Operating profit (EBITDA) | 0.5 | 0.6 | −29% |
| Operating margin | 5.2% | 8.2% | −3.0 pts |
| Net profit | 0.3 | 0.4 | −21% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.